Organ involvement in systemic sclerosis
DOI:
https://doi.org/10.5457/ams.v55i1.850Keywords:
cardiac involvement, renal involvement, Rodnan skin score, systemic sclerosisAbstract
Introduction: In systemic sclerosis, several organ systems can be affected, due to the basic pathophysiological mechanism at the endothelial level.
Aim: The aim of this research is to show the frequency of clinical manifestations as well as their correlation in our sample of patients.
Methods: Twenty-nine patients with systemic sclerosis were included in our study. A correlation was made between clinical manifestations, parameters and organic involvement.
Results: The number of patients who had esophageal involvement was 16 (55.2%), cardiac involvement 18 (62.1%), pulmonary 27 (93.1%) and renal 16 (55.2%). The occurrence of esophageal, cardiac and renal involvement was statistically significant in correlation with disease duration (p=0.017, p=0.014; p=0.032). The appearance of digital ulcerations (DU) was significantly correlated with esophageal and cardiac involvement, p=0.034 and p=0.01. Reduction of renal involvement, decrease in creatinine clearance and thinning of the renal parenchyma, occurred simultaneously with cardiac involvement in a statistically significant correlation, p= 0.014 and p=0.011. The reduction in ejection fraction and the occurrence of diastolic dysfunction also affected renal involvement, p= 0.009 and p=0.017.
Conclusion: We showed a correlation between the duration of the disease and organic involvement, as well as DU with cardiac and esophageal involvement. The connection between the cardiac and renal systems affects the overall course of the disease and the higher mortality of patients. Therefore, with early detection, adequate management and therapeutic modalities can be accessed in a timely manner in order to prevent further complications of the course of the disease.
References
Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017; 390:1685-99.
Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis. Arthritis Rheum. 2000; 43: 2445-54.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Murray B, Tyndall A et al. Cassification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72:1747–55.
Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. Journal of Scleroderma and Related Disorders. 2017; 2(1):11-8.
Siraj QH, Buscombe JR, Kaye SA, Agnew JE, Black CM, Hilson AJW. Esophageal Scintigraphy in Systemic Sclerosis: A Simplified Imaging and Reporting Method. J Nucl Med Technol. 1996; 24:316-20.
Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S et al. Tricuspid Annular Plane Systolic Excursion and Pulmonary Arterial Systolic Pressure Relationship in Heart Failure: An Index of Right Ventricular Contractile Function and Prognosis. Am J Physiol Heart Circulatory Physiol. 2013. 305:1373–81.
Quanjer PH, Tammeling GJ, Cotes JE, Pederson OF, Peslin R, Yernault JC. Lung Volumes and Forced Ventilatory Flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16:5–40.
Wang X, Vrtiska TJ, Avula RT, Walters LR, Chakkera HA, Kremers WK et al. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int. 2014; 85:677–85.
Takata T, Koda M, Sugihara T, Sugihara S, Okamoto T, Miyoshi K et al. Left renal cortical thickness measured by ultrasound can predict early progression of chronic kidney disease. Nephron. 2016; 132:25–32.
Westerling H, Bairkdar M, Gunnarsson K, Moshtaghi-Svensson J, Sysojev AO, Hesselstrand R et al. Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study. Seminars in Arthritis and Rheumatism. 2022; 53:151978
Coi A, Barsotti S, Santoro M, Almerigogna F, Bargagli E, Caproni M et al. Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy). Orphanet J Rare Dis. 2021; 16: 90.
Ferreira Morales J, Guitierrez Tamayo AM, de Olaya EB, Rodriguez Padilla LM, Velasquez-Franco CJ, Mesa Navas MA. Úlceras digitales en esclerosis sistémica. Rev Colomb Reumatol. 2020;27:2–9.
Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol. 2018; 37:2103–11.
Asif S, Khan A, Faiq M, Din ZU, Zahoor S, Haroon M. Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan. Arch Rheumatol 2021; 36(4):587-94
Janga HJ, Woob A, Kimb SY, Yongb SH, Parkb Y, Chungb K et al. Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease. ANNALS OF MEDICINE. 2023; 55 (1):663–71.
Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S et al. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res Ther. 2019; 21: 129.
Cozzani E, Muracchioli A, Murdaca G, Beccali M, Caprioli S, Zentilin P et al. Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications. Front. Immunol. 2021; 12:588753.
Weinstein JR, Anderson S. The Aging Kidney: Physiological Changes. Adv Chronic Kidney Dis. 2010; 17:302–7
Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J, Canadian scleroderma research gropu. Association with digital ulcers in a large cohort of systemic sclerosis: Results from the canadian scleroderma research group registry. Arthritis Care & Research. 2011;63(1):142-149
Scheja A, Bartosik I, Wuttge DM, Hesselstrand R. Renal function is mostly preserved in patients with systemic sclerosis. Scand J Rheumatol. 2009; 38:295–8
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
